Evaluation of incidence and survival of patients with borderline ovarian tumors in Sweden MATERIAL AND METHODS: All women diagnosed with borderline ovarian tumor in the Swedish Cancer Register 1960-2007 (n=6,252) combined with follow-up in the Swedish Death Registry to 1 July 2009 were included. Estimation of age-standardized relative survival rate according to time periods for diagnosis RESULTS: The incidence of borderline ovarian tumors increased during the study period, with a steep increase during the 1980-ies. The age standardized 5 year relative survival including all borderline tumors diagnosed 2000-2007 was 97% (95% confidence interval: 92-99%). In women age 64 or younger 10 year relative survival related to age at diagnosis of bord...
WOS: 000399391600006Purpose: The aim of this study was to evaluate the borderline ovarian tumor case...
Objective: To determine the borderline ovarian tumors according to clinical features, treatment met...
Background: Population-based data on borderline ovarian tumors (BOTs) are scarce and information reg...
Background: Population-based data on borderline ovarian tumors (BOTs) are scarce and information reg...
Sixty-two patients with borderline tumors of ovary were historical cohort analyzed for survival char...
The aim of this study was to determine the prognosis and survival for patients with borderlineovaria...
Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the ...
Background: Borderline ovarian tumours (BOT) are an intermediate form of neoplasia, between benign a...
Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the ...
Background: Borderline ovarian tumors are histologically characterized as epithelial tumors with a s...
A total of 1,197 borderline ovarian tumors were reported to the Finnish Cancer Registry in 1973-1992...
Over a fourteen-year period, 1970-1984, 213 patients with malignant ovarian tumors were seen at Moun...
The objective of the present study was to evaluate the clinicopathological features and the survival...
Background: Borderline ovarian tumors are non-invasive tumors that display greater epithelial prolif...
Objective: The aim of this study is to describe occurrence and treatment of BOTs (Borderline Ovarian...
WOS: 000399391600006Purpose: The aim of this study was to evaluate the borderline ovarian tumor case...
Objective: To determine the borderline ovarian tumors according to clinical features, treatment met...
Background: Population-based data on borderline ovarian tumors (BOTs) are scarce and information reg...
Background: Population-based data on borderline ovarian tumors (BOTs) are scarce and information reg...
Sixty-two patients with borderline tumors of ovary were historical cohort analyzed for survival char...
The aim of this study was to determine the prognosis and survival for patients with borderlineovaria...
Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the ...
Background: Borderline ovarian tumours (BOT) are an intermediate form of neoplasia, between benign a...
Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the ...
Background: Borderline ovarian tumors are histologically characterized as epithelial tumors with a s...
A total of 1,197 borderline ovarian tumors were reported to the Finnish Cancer Registry in 1973-1992...
Over a fourteen-year period, 1970-1984, 213 patients with malignant ovarian tumors were seen at Moun...
The objective of the present study was to evaluate the clinicopathological features and the survival...
Background: Borderline ovarian tumors are non-invasive tumors that display greater epithelial prolif...
Objective: The aim of this study is to describe occurrence and treatment of BOTs (Borderline Ovarian...
WOS: 000399391600006Purpose: The aim of this study was to evaluate the borderline ovarian tumor case...
Objective: To determine the borderline ovarian tumors according to clinical features, treatment met...
Background: Population-based data on borderline ovarian tumors (BOTs) are scarce and information reg...